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Abstract
Background: Anthrax edema toxin (EdTx) is an adenylate cyclase which operates in the perinuclear region of host cells.
However, the action of EdTx is poorly understood, especially at molecular level. The ability of EdTx to modulate cAMP-
dependent signaling was studied in Jurkat T cells and was compared with that of other cAMP-rising agents: Bordetella
pertussis adenylate cyclase toxin, cholera toxin and forskolin.
Methodology/Principal Findings: EdTx caused a prolonged increase of the intracellular cAMP concentration. This led to
nuclear translocation of the cAMP-dependent protein kinase (PKA) catalytic subunit, phosphorylation of cAMP response
element binding protein (CREB) and expression of a reporter gene under control of the cAMP response element. Neither
p90 ribosomal S6 kinase nor mitogen- and stress-activated kinase, which mediate CREB phosphorylation during T cell
activation, were involved. The duration of phospho-CREB binding to chromatin correlated with the spatio-temporal rise of
cAMP levels. Strikingly, EdTx pre-treated T cells were unresponsive to other stimuli involving CREB phosphorylation such as
addition of forskolin or T cell receptor cross-linking.
Conclusions/Significance: We concluded that, in a first intoxication phase, EdTx induces PKA-dependent signaling, which
culminates in CREB phosphorylation and activation of gene transcription. Subsequently CREB phosphorylation is impaired
and therefore T cells are not able to respond to cues involving CREB. The present data functionally link the perinuclear
localization of EdTx to its intoxication mechanism, indicating that this is a specific feature of its intoxication mechanism.
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Introduction
Anthrax is caused by Bacillus anthracis, a Gram-positive,
sporulating bacterium. This organism is commonly found in soil
and it mainly infects large herbivores, but occasionally also
humans. The spores can enter the body from skin abrasions, the
gastro-intestinal tract, or the lungs. Whilst cutaneous anthrax has
only local effects, the gastro-intestinal and inhalation forms may
lead to a systemic infection, causing septicemia and toxemia.
Fatality of inhalation anthrax is very high [1,2]. Even though B.
anthracis is sensitive to different antibiotics, their therapeutic benefit
is frequently diminished by the late onset of symptoms. Therefore,
in recent years much research focused at finding new therapeutics
that block the action of anthrax toxins, which are major virulence
factors of B. anthracis [3].
Pathogenic strains of B. anthracis harbor three plasmid-encoded
virulence factors: a polyglutamic capsule and two A–B toxins [2,4].
These toxins consist of two enzymatic components, edema factor
(EF) and lethal factor (LF) which share their B carrier, termed
anthrax protective antigen (PA) [5]. PA can associate with two cell
surface receptors, tumor endothelial marker 8 (TEM8) and
capillary morphogenesis protein 2 (CMG2) [6,7], and possibly
with the co-receptor low-density lipoprotein receptor-related
protein LRP6 [8–10]. On to the cell surface, PA forms a
heptamer that binds up to three molecules of EF or LF [5]. After
endocytosis, at low pH, the heptamer dissociates from the
receptors and inserts into the lipid bilayer forming a pore through
which partially unfolded EF and LF cross the membrane [11]. The
slightly acidic pH of early endosomes is sufficient to mediate the
detachment of toxins from TEM8, but the more acidic pH of late
endosomes (LEs) is required for their dissociation from CMG2
[12]. However, it was proposed that LF rarely translocates directly
to the cytosol from the limiting membrane of endosomes; more
frequently it is delivered to intralumenal vesicles (ILVs) which then
release the toxin upon back-fusion with the limiting membrane at
the LE stage [13–15]. EF was found to remain attached to the
cytosolic side of LE membrane, whereas LF freely diffuses into the
cytosol [13,16,17].
EF and LF act on many cell types, but their action on cells of
both innate and adaptive immunity appears particularly relevant
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3564as it allows B. anthracis to survive the host defense mechanisms. In
some cell types, the two toxins act in synergism [18,19]. EF and LF
affect fundamental signaling pathways linking extracellular stimuli
to cell function. LF is a Zn-dependent metalloprotease that cleaves
the N-terminal portion of most isoforms of the mitogen activated
protein kinase kinases (MAPKKs or MEKs) [20], thus disrupting
MEK-dependent signaling [5,19]. The action of EF is less
understood. EF is a calmodulin-dependent adenylate cyclase that
perturbs ion homeostasis and cell signaling by increasing the
cytosolic cAMP concentration [5,19]. Injection of PA+EF (edema
toxin, EdTx) into mice causes tissue lesion and death [21].
EdTx-induced alterations of cell signaling are generally thought
to be inhibitory and to be mediated by cAMP-dependent protein
kinase (PKA) [19]. In particular, CD4
+ T cells were identified as
targets of anthrax toxins in vitro and ex vivo [22–24]. EdTx is able to
suppress T cell proliferation and to inhibit cytokine release
[22,24]. MEK, ERK and JNK phosphorylation were found to be
affected by EdTx in cells activated by T cell receptor (TCR) cross-
linking, which resulted in reduced activity of the transcription
factors NF-AT and AP-1 [22,24]. Similarly, EdTx inhibits T cell
chemotaxis by downregulation of ERK phosphorylation [25].
These effects were attributed to the inhibitory action of PKA on
upstream kinases of the MAPK family, among which Raf.
Nevertheless, targets of PKA in EdTx-triggered signaling are
scarcely defined.
Using Jurkat T cells, we studied the impact of EdTx-mediated
intracellular cAMP elevation on PKA- and cAMP response
element binding protein (CREB)-dependent signaling and dem-
onstrated that EdTx activates gene expression. We report that
EdTx generates an extremely enduring increase in cAMP levels,
which stimulates nuclear translocation of the PKA catalytic
subunit and phosphorylation of CREB. This in turn allows
binding of phosphorylated CREB (pCREB) to chromatin and
transcription of a reporter gene under control of the cAMP
response element (CRE). Further, we found that pre-treatment
with EdTx prevents phosphorylation of CREB induced by a
cAMP stimulus or by TCR cross-linking. Comparison with other
cAMP-elevating agents showed that length and site of cAMP
synthesis are crucial to modulation of gene transcription, which
indicates that prolonged perinuclear production of cAMP is a
specific and functional feature of EdTx intoxication mechanism.
Materials and Methods
Reagents, plasmids, and proteins
All chemicals were p.a. grade or higher and purchased from
Sigma, together with forskolin, cholera toxin (CT), and poly-D-
lysine. Protease inhibitor tablets (complete, devoid of EDTA) were
purchased from Roche. Adefovir dipivoxil was a kind gift of Gilead
(CA, USA). Roswell Park Memorial Institute Medium (RPMI)
1640 and fetal bovine serum (FBS) were bought from Invitrogen.
Antibiotics and L-glutamine were purchased from GIBCO.
Antibodies against CREB and pCREB (phospho-S133) were
purchased from Upstate, against tetra-acetyl-histone H4, pRSK1/
2 p90 (phospho-S380), pMSK1 (phospho-T581) from Abcam,
against CD3 (OKT3) from eBioscience, against actin from Sigma.
Secondary antibodies and H-89 dihydrochloride were obtained
from Calbiochem. Plasmids pcDNA3-RII-CFP and pcDNA3-C-
YFP coding, respectively, for the regulatory subunit of PKA fused
to cyan fluorescent protein and for the catalytic subunit of PKA
fused to yellow fluorescent protein were as in [26]. Plasmids
pCRE-Luc and pRL-TK were obtained from Clontech and
Promega, respectively. PA [27], EF [16], and CyaA [28] were
prepared as previously described. Endotoxin contamination was
monitored with PyroGene-rFC Endotoxin Detection System
(Lonza) and was found in all preparations to be below 0.5
endotoxin units/mg protein.
Cell culture
E6.1 Jurkat T cells were kept in RPMI 1640, supplemented with
100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-gluta-
mine, 10 mM Hepes and 10% heat-inactivated FBS. Cells were
maintained at 37uC and 5% CO2 in a humid environment.
Cell viability test
Viability of Jurkat cells was assessed by measuring the oxidation
of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) (MTS) using the CellTiter96 Aque-
ous One Solution Cell Proliferation Assay (Promega) 12 h, 24 h,
48 h, and 72 h after treatment with 10 nM EF+40 nM PA (final
concentration hereafter), 3 nM CT, 5 nM CyaA, 25 mM forskolin
(in DMSO, from a 10 mM stock solution), 1:400 (vol/vol) DMSO,
10 nM EF, or 40 nM PA.
Determination of the cellular content of cAMP
5610
5 Jurkat cells in 200 ml were prepared the evening before
the determination and stimulated for the indicated times with
10 nM EF+40 nM PA, 3 nM CT, 5 nM CyaA, 25 mM forskolin,
or left untreated. 5 mM adefovir dipivoxil (in DMSO, from a
0.5 mM stock solution) was added 2 to 12 h before stimulation
with EdTx and was reapplied 4 h after the first addition. Samples
were prepared in triplicates. The culture medium was removed
after 10 min of centrifugation at 1300 rpm and 4uC and the cells
immediately processed for intracellular cAMP measurement by
enzyme-linked immunoassay following the manufacturer’s instruc-
tion (Biotrak EIA, GE Healthcare). The number of cells present in
each sample was determined separately using a Bu ¨rker chamber.
Plasmid preparation and transfection of Jurkat cells
Plasmids pcDNA3-C-YFP, pcDNA3-RII-CFP, pCRE-Luc, and
pRL-TK were propagated in CaCl2-competent Escherichia coli XL-
1Blue cells that were transformed by the heat shock method [29].
To purify plasmid DNA, a Maxi-Prep (QIAGEN) was performed
according to the manufacturer’s instructions. 9610
6 of Jurkat cells
in 30 ml of culture medium were prepared the evening before
transfection. 20 mg each of pcDNA3-RII-CFP and pcDNA3-C-
YFP or 20 mg pCRE-Luc and 1 mg pRL-TK were introduced into
cells kept in 400 ml of culture medium devoid of FBS giving an
electric shock at 250 V and 950 F in electroporation cuvettes with
0.4 cm gap (Bio-Rad) using a GenePulser Xcell electroporator
(Bio-Rad). The FBS content was brought back to 10% and cells
allowed to grow a few hours at a concentration of 5610
5 cells/ml.
Imaging of the nuclear translocation of PKA catalytic
subunit
48 h after transfection with pcDNA3-RII-CFP and pcDNA3-C-
YFP, cells were stimulated with 10 nM EF+40 nM PA, 3 nM CT,
5 nM CyaA, 25 mM forskolin, or left untreated and at the
indicated times allowed to adhere for 10 min to cover slips coated
with poly-D-lysine (50 mg/ml). Cells were paraformaldehyde-fixed
according to standard protocols. Z-stacks of samples with 0.27 mm
width were acquired at 490 nm on a DMIRE2 fluorescence
microscope (Leica), equipped with a Leica DC 500 CCD camera,
using a 636 oil immersion objective with NA 1.4 and 1.56
magnification. Images were deconvoluted with the software
LeicaDeblur and the maximal projection created in WCIF Image
J [30].
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Jurkat cells were treated for the indicated times with 10 nM
EF+40 nM PA, 3 nM CT, 5 nM CyaA, 25 mM forskolin, or left
untreated. To induce TCR cross-linking, cells were transferred for
30 min to plates coated over night with antibody against CD3
(10 mg/ml in PBS). Samples containing 10
5 cells were lysed on ice
for 10 min under rotation in the presence of protease inhibitors
and heated for 8 min to 95uCi n6 0ml Laemmli buffer [31]. 10 mg
of protein per lane were subjected to SDS-PAGE on 12%
polyacrylamide gels at room temperature and 20 mA per gel and
transferred at 200 mA to nitrocellulose in a refrigerated chamber.
Membranes were incubated with the appropriate antibodies
following the manufacturer’s instructions. When necessary,
membranes were stripped by 30 min incubation at 50uCi n
62.5 mM Tris/HCl pH 6.7, 2% (w/v) SDS, 1 mM 2-mercapto-
ethanol, thoroughly rinsed and re-probed. Chemiluminescence
was developed with ECL Plus or ECL Advance western blotting
detection system (GE Healthcare) and emission was measured with
ChemiDoc XRS (Bio-Rad). Band intensities were quantified on
the original files with the software Quantity One (Bio-Rad). None
of the bands was saturated. Band intensities of blots against CREB,
pCREB, pRSK1/2 and pMSK1 were corrected with the
intensities of the loading control actin and set equal to 1 at t=0.
Luminescence assay
The day after transfection with pCRE-Luc and pRL-TK, cells
were stimulated with 10 nM EF+40 nM PA, 3 nM CT, 5 nM
CyaA, or 25 mM forskolin. As controls, 1:400 (vol/vol) DMSO,
10 nM EF, or 40 nM PA were added or cells were left untreated.
Cells were lysed on ice for 10 min in the presence of protease
inhibitors and luciferase activity was assayed immediately using
the Dual-Luciferase Reporter Assay System (Promega) as
described by the manufacturer. For each time point, 10
5 cells
were present. Samples were prepared in triplicates. For every
Figure 1. Time course of cAMP production by Jurkat cells stimulated with EdTx, CT, CyaA, or forskolin. Jurkat T cells were stimulated for
the indicated times with EdTx (10 nM EF+40 nM PA), CT (3 nM), CyaA (5 nM), or forskolin (25 mM). At the end of the incubations, the samples, which
contained 10
5 cells, were lysed and immediately subjected to competition ELISA in order to determine the amount of cAMP present. Adefovir
dipivoxil, a specific inhibitor of EdTx, abolished cAMP synthesis in EdTx-treated cells (not shown). Note the different cAMP scales in the four panels.
Experiments were not normalized to percentage values to provide the actual levels of cAMP. Data are the mean and standard deviation of four
independent experiments for EdTx and three for CT, CyaA and forskolin, performed in triplicates.
doi:10.1371/journal.pone.0003564.g001
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renilla luciferases and the firefly luciferase activity per mgo f
protein in cell lysates were obtained. Proteins were quantified by
the Bradford method (Biorad Protein Assay).
Chromatin immunoprecipitation
The evening before the experiment, 5610
5 Jurkat cells were
inoculated into 2 ml culture medium. The following day, they
were treated for the indicated times with 10 nM EF+40 nM PA,
or 3 nM CT, or 5 nM CyaA, or 25 mM forskolin, or DMSO
(1:400 vol/vol), or left untreated. Proteins and DNA were cross-
linked by addition of 1% (w/v) formaldehyde directly to the
culture medium and incubation for 10 min at 37uC. The reaction
was stopped with 125 mM glycine in PBS. Cells were washed with
ice-cold PBS containing protease inhibitors and lysed on ice for
10 min under rotation in the presence of protease inhibitors. DNA
was sheared to fragments of about 600 bp by three cycles of 10 s of
ultrasonic dispersion using a Fisher Sonic Dismembrator Model
300 at 30% power output with a 4 mm tip. The lysates were
subjected to chromatin immunoprecipitation according to the
manufacturer instructions using the kit produced by Upstate,
including standard controls such as absence of antibody and
presence of unspecific rabbit IgG. 15 ml of anti-pCREB antibody
were employed. Samples were processed for SDS-PAGE and
subjected to western blotting with an antibody against tetra-acetyl-
histone H4.
Results
Time course of cAMP production
The concentrations of the toxins and drugs used here were
deduced from the literature. In fact, the concentration of EdTx, CT,
and CyaA in circulating fluids during pathogenesis is not yet known.
The selected toxin concentrations were either within or below the
affinity range of these toxins for their respective cell surface receptor
[32–36]. One can reasonably hypothesize that such toxin concen-
trations will be found in vivo. In particular, the present concentration
of 10 nM EdTx was chosen on the basis of our previous cellular
studies [16,24,25] and is by far lower than the estimated 150 nM
tissue fluid concentration used in a recent study of EdTx toxicity in
mice [21]. Indeed, cell viability and growth were unaffected by
EdTx, CT, CyaA, and forskolin at the concentrations we employed
for the duration of the experiments (not shown).
The time course of total intracellular cAMP synthesis in Jurkat T
cells following treatment with EdTx, CT, CyaA and forskolin was
determined by competition ELISA. Although this approach is not as
sensitive as the previously used FRET-based live imaging of
intracellular cAMP production [16], it allows to measure the total
cAMP content over a prolonged period of time. All four agents
induced a rise of intracellular cAMP levels, however the kinetics and
the amounts of produced cAMP strongly differed among them
(Fig. 1). Addition of EdTx (10 nM EF+40 nM PA) lead to a rise of
the intracellular cAMP concentration that was appreciable after 2 h
and, strikingly, increased steadily during the following 24 h,
producing up to 4300 fmol of cAMP per 10
5 Jurkat cells. Using
FRET-based live imaging of EdTx activity, we previously found that
cAMP levels start rising 30–40 min after toxin addition [16].
Synthesis of cAMPwas suppressed by adefovir dipivoxil (not shown),
a specific inhibitor of EdTx [37]. Stimulation of Jurkat cells with
3 nM CT induced a rapid, but limited rise in intracellular cAMP
concentration that attained the highest level 2 h after toxin addition
(about 80 fmol of cAMP per 10
5 cells) and then slowly decayed.
Addition of 5 nM CyaA induced an immediate rise in cAMP
concentration that reached its maximum 30–60 min after addition
with about 450 fmol per 10
5 Jurkat cells, maintained these cAMP
levels for another 1.5 h, and then progressively decayed. Forskolin
Figure 2. Activation and nuclear translocation of PKA catalytic subunit upon stimulation of Jurkat cells with EdTx, CT, CyaA, or
forskolin. Cells were transiently transfected with a fluorescent probe coding for the PKA catalytic subunit fused to yellow fluorescent protein,
stimulated with EdTx (10 nM EF+40 nM PA), CT (3 nM), CyaA (5 nM), or forskolin (25 mM), fixed and observed at the microscope. a) in resting cells, the
catalytic subunit of PKA resides within the ring-shaped cytoplasm. b) 1.5 h after addition of EdTx, the majority of the PKA catalytic subunit is still
present in the cytosol, whilst c) after 8 h it is inside the nucleus. The migration of PKA catalytic subunit induced by CT, CyaA, and forskolin after 1.5 h
are shown in panels d), e) and f), respectively.
doi:10.1371/journal.pone.0003564.g002
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indicated times, lysed and processed for western blotting using an antibody against S133-pCREB. On each lane 10 mg of protein were loaded. Upper
panel, western blots depicting the time course of EdTx (10 nM EF+40 nM PA), CT (3 nM), CyaA (5 nM), and forskolin (25 mM) dependent CREB
phosphorylation. Lower panels, the graphs report the quantitative analysis of the kinetics of CREB phosphorylation induced by EdTx, CT, CyaA, and
forskolin (solid line with filled circles). Untreated samples are depicted by the dotted line with black triangles. The intensity of each band was
determined using the software Quantity One (Bio-Rad) and was corrected for different loadings using the corresponding value of actin as control. The
value at time 0 was set equal to 1. The total amount of cellular CREB did not change during the time course of CREB phosphorylation (not shown).
The blots show one representative experiment and the data in the graphs are the mean and standard deviation of three independent experiments.
doi:10.1371/journal.pone.0003564.g003
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concentration with 4400 fmol of cAMP per 10
5 Jurkat cells.
Activation of PKA
Next, we tested the possibility that the toxin- or forskolin-
induced rise in cAMP concentration could activate PKA and drive
the consequent nuclear translocation of its catalytic subunit. We
imaged PKA in cells by transiently expressing a fluorescent probe
consisting of the PKA catalytic subunit fused to YFP. As expected,
in resting Jurkat cells the catalytic subunit of PKA resided in the
ring-shaped cytosol (Fig. 2a). To the contrary, upon stimulation
with EdTx (10 nM EF+40 nM PA), CT (3 nM), CyaA (5 nM), or
forskolin (25 mM) the catalytic subunit translocated to the nucleus
(Fig. 2b–f). According to the respective kinetics of intracellular
cAMP increase of the different toxins, the catalytic subunit of PKA
diffused into the nucleus with different time courses.
Phosphorylation of CREB
This result suggested to study the functional consequence of the
nuclear migration of PKA on the phosphorylation of CREB,
which is the best characterized cAMP-regulated transcription
factor [38–41]. Western blot analysis of the active, S133-
phosphorylated form of CREB from EdTx (10 nM EF+40 nM
PA), CT (3 nM), CyaA (5 nM), or forskolin (25 mM) stimulated
cells are shown in Fig. 3. A precise quantification of CREB
phosphorylation kinetics was then obtained from the ratios of the
pCREB signal to that of the actin level, which were determined on
the same blots with an actin-specific antibody (not shown). The
time course of CREB phosphorylation resembled the time course
of cAMP production, except for EdTx at late time points. Indeed,
EdTx action started with a delay of about 45 min and then
exhibited a strongly sustained CREB phosphorylation, which
reached the maximum around 6 h (Fig. 3). Notably, a high level of
pCREB was maintained until 12 h after toxin addition, but it then
returned to basal levels in spite of the rising concentration of
intracellular cAMP (Fig. 1), most likely owing to the activation of
negative feedback mechanisms [41]. CT had a lag of about 45 min
before significant CREB phosphorylation could be observed,
which peaked 1.5 h after stimulation and came down to basal
levels after 6 h (Fig. 3). At the maxima, the amounts of pCREB
produced in response to CT were comparable to those produced
by EdTx. CyaA triggered a very rapid phosphorylation of CREB
(appreciable 15 min after toxin addition), reaching a maximum
after 1.5 h and followed by a smooth decay that was completed
after 10–12 h (Fig. 3). At their maxima, the quantity of pCREB
produced by CyaA was comparable to those induced by EdTx and
CT. Finally, forskolin mediated a time course of CREB
phosphorylation that was very similar to that of CyaA (Fig. 3).
However, at the maximum, the amount of pCREB synthesized in
response to forskolin was higher than in the presence of EdTx,
CT, and CyaA. The total cellular amount of CREB, which was
assayed on the same samples by western blotting with an anti-
CREB antibody, did not vary during the treatment with EdTx,
CT, CyaA, and forskolin (not shown). These cAMP-elevating
agents also induced phosphorylation of the CREB-related
transcription factor ATF-1, which was observable by western blot
with the anti-pCREB antibody owing to the common presence of
a phosphorylated serine epitope (not shown).
Specificity of CREB phosphorylation by PKA
We further addressed the question whether phosphorylation of
CREB depended only on PKA or also on other factors that could be
activated by cAMP in Jurkat T cells. To this end, we monitored
EdTx-,CT-,CyaA-,andforskolin-mediatedCREBphosphorylation
in the presence and absence of the inhibitor H-89 dihydrochloride,
which is commonly used to discriminate between the effects of PKA
from those of other kinases, as well as of the guanine nucleotide
exchangefactorEpac.Epaccaninduce phosphorylationofCREBin
a Rap1- and MAPK-dependent way [38,42,43] and was found to
mediate EdTx-induced inhibition of endothelial cell chemotaxis
[44]. In the presence of 20 mM H-89, CREB phosphorylation
induced by EdTx (10 nM EF+40 nM PA), CT (3 nM), CyaA
(5 nM), or forskolin (25 mM) was strongly inhibited (Fig. 4).
However, H-89 has been reported to affect the activity of
mitogen/stress activated kinases [45], which can phosphorylate
CREB [39–41] and, interestingly, CREB phosphorylation during T
cell activation is dependent on RSK2 [46,47] and MSK1 [48]. We
therefore verified whether this kinase family might have been
activatedinTcellsbythecAMP-modulatingtoxins.Jurkatcellswere
incubated with EdTx, CT, CyaA, or forskolin over a range of 24 h
and analyzed by western blotting using antibodies directed against
the active, S380-phosphorylated isoforms 1 and 2 of p90 ribosomal
S6 kinase (RSK) and against the active, T581-phosphorylated
mitogen- and stress-activated protein kinase(MSK) 1. Wefound that
the phosphorylation levels of RSK1/2 and of MSK1 were not
affected by any of the toxin or drug added (not shown).
Expression of a CRE-driven reporter gene
To test whether the phosphorylation of CREB described above
could lead to gene transcription through its cognate activator
sequence cAMP response element (CRE), Jurkat cells were double-
transfected with two plasmids, one coding for firefly luciferase
under the control of CRE and the other coding for renilla
luciferase under the control of a viral promoter with constitutive
transcriptional activity. Stimulation of pCREB transcriptional
activity in the transfected cells will result in an increase of the ratio
of firefly luciferase activity to that of renilla luciferase activity.
Indeed, as shown in Fig. 5, EdTx (10 nM EF+40 nM PA), CT
Figure 4. PKA-dependent phosphorylation of CREB upon
stimulation of Jurkat cells with EdTx, CT, CyaA, or forskolin.
Cells were stimulated for the indicated times with EdTx (10 nM
EF+40 nM PA), CT (3 nM), CyaA (5 nM), or forskolin (25 mM) in the
presence or absence of 20 mM H-89 dihydrochloride, an inhibitor of
PKA, lysed and processed for western blotting using an antibody
against S133-pCREB. On each lane 10 mg of protein were loaded.
Different loading was controlled by staining against actin. In separate
experiments, RSK1/2 and MSK1, which mediate CREB phosphorylation
during T cell activation, were found not to be activated following T cell
stimulation with EdTx, CT, CyaA and forskolin (not shown). The
experiment shown is representative of four performed.
doi:10.1371/journal.pone.0003564.g004
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expression of the CRE-controlled gene. In the presence of EdTx
no activation of firefly luciferase expression could be detected
before 3 h after addition, compared to 1.5 h in the presence of
CT, CyaA and forskolin. In the same samples, firefly luciferase
activity per mg of protein in cell lysates was also determined and
very similar results were obtained (not shown).
Duration of pCREB binding to chromatin and
transcriptional activation
The use of a reporter system has shown that EdTx, CT, CyaA,
and forskolin are capable of inducing expression of a gene
regulated by CRE. However, a CRE-driven reporter assay is a
highly simplified system with respect to transcription of cellular
genes, where several distinct promoter sequences control this
process. Therefore, to test for the association of pCREB with
transcriptionally active genomic DNA, we immunoprecipitated
pCREB and determined the amount of associated chromatin by
western blotting with an antibody specific for the acetylated
histone H4, which is present in CREB-activated genes [49,50].
Fig. 6 shows that EdTx, CT, CyaA, and forskolin are able to
promote the association of pCREB with transcriptionally active
chromatin, as the amount of precipitated pCREB-bound DNA
increased following their addition with respect to untreated
samples. However, the duration of pCREB binding to chromatin
induced by the different cAMP-elevating agents varied signifi-
cantly. In fact, whereas EdTx and CT triggered an enduring
Figure 5. Expression of a reporter gene under the control of CRE upon stimulation of Jurkat cells with EdTx, CT, CyaA, or forskolin.
Cells were double-transfected with plasmids coding for firefly luciferase under the control of the inducible promoter CRE and for renilla luciferase
under the control of a viral promoter with basal transcriptional activity. Each sample contained 10
5 cells that were lysed and immediately processed
for a chemiluminescence assay. The ratio between the activity of firefly and renilla luciferases is plotted. An increasing value of this ratio indicates that
the gene regulated by CRE is expressed. Samples stimulated with EdTx (10 nM EF+40 nM PA), CT (3 nM), CyaA (5 nM), or forskolin (25 mM) are
depicted by solid lines with filled circles, whereas untreated samples are represented by dotted lines with filled triangles. EF and PA alone failed to
mediate expression of firefly luciferase, whilst DMSO induced a very slight response (not shown). For every sample, firefly luciferase activity per mgo f
protein in cell lysates was also obtained, giving very similar results (not shown). The data are the mean and standard deviations of four independent
experiments performed in triplicates.
doi:10.1371/journal.pone.0003564.g005
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declined much more rapidly.
Inhibition of CREB phosphorylation in cells pre-treated
with cAMP-rising agents
The fact that phosphorylation of CREB caused by EdTx was
terminated after 14 h (Fig. 3) in spite of the continuously raising
intracellular cAMP concentration (Fig. 1) suggested that negative
feedback mechanisms are activated. To test whether these
mechanisms could suppress CREB re-phosphorylation after a first
activation provoked by EdTx (10 nM EF+40 nM PA), CT (3 nM),
CyaA (5 nM), or forskolin (25 mM), we treated Jurkat cells with
these cAMP-elevating agents for 16 h or 24 h (at these time points
the levels of pCREB had returned to basal) and then re-stimulated
CREB phosphorylation by addition of 25 mM forskolin or by anti-
CD3 mediated cross-linking of the TCR. As shown in Fig. 7, EdTx
abolished re-phosphorylation of CREB induced both by forskolin
and by TCR-cross-linking. At variance, CT strongly inhibited
TCR-mediated CREB re-phosphorylation, but not CREB re-
activation provoked by forskolin. CyaA slightly diminished CREB
re-phosphorylation mediated by forskolin and TCR cross-linking.
Restimulation of forskolin-treated cells with the same agent, i. e.
forskolin, resulted in strong inhibition of CREB re-activation, but
allowed CREB re-phosphorylation following TCR cross-linking.
Discussion
EdTx-mediated suppression of T cell activity is generally
thought to be achieved by inhibition of MAPK-dependent
signaling. The present data indicate that EdTx also targets
Figure 6. Duration of pCREB binding to chromatin upon stimulation of Jurkat cells with EdTx, CT, CyaA, or forskolin. Cells were
treated for the indicated times with EdTx (10 nM EF+40 nM PA), CT (3 nM), CyaA (5 nM) and forskolin (25 mM). Protein and DNA were cross-linked
with formaldehyde, then cells were lysed and chromatin was sheared to 600 bp fragments by sonication. Fragmented, transcriptionally active
chromatin binding pCREB was recovered by immunoprecipitation of chromatin with a S133-pCREB specific antibody and quantified by western
blotting using an antibody specific for acetylated histone H4, which is present in transcriptionally active DNA. The amount of precipitated chromatin
at t=0 was set equal to 1. DMSO, the vehicle of forskolin, induced a very slight increase in pCREB association with transcriptionally active chromatin
(not shown). The data shown are the mean and standard deviations of three independent experiments.
doi:10.1371/journal.pone.0003564.g006
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phosphorylation of CREB are tightly regulated in space and time
during T cell activation [46,51,52] and many of the activated
genes are regulated by CRE [46]. Therefore, toxin-mediated
alterations of the spatio-temporal synthesis of cAMP appears to be
a potent way exploited by pathogens to block T cell activity.
We report here that EdTx mediates an extremely prolonged rise
of cAMP levels, whereas CT-, CyaA- and forskolin-induced
elevations of cAMP concentration are transient. This sustained
action might be explained either by enduring catalytic activity of
EdTx in the cytosol due to high resistance to proteolytic
degradation or be linked to its mode of cell entry. In fact, EdTx
exploits the endocytic route to reach the cytosol and was proposed
to associate with ILVs [13]. These vesicles may function as toxin
stores that, upon gradual back-fusion with the limiting membrane
of LEs, could progressively release EdTx into the cytosol to
produce high amounts of cAMP over a long period of time [15].
The prolonged rise in cAMP levels elicited by EdTx also resulted
in long-lasting phosphorylation of CREB. EdTx, CT, CyaA and
forskolin were all able to induce transcription of a reporter gene.
However, EdTx and, to a lesser extent, CT appeared to be more
efficient in promoting enduring pCREB association with transcrip-
tionally active chromatin. This is consistent with the generally
accepted findingthat stimuli canprovoke phosphorylationofCREB
with comparable kinetics and stoichiometry, yet not all stimuli are
able to induce pCREB-mediated transcription to the same extent
[39,41]. Clearly, the ability of EdTx, CT, CyaA and forskolin to
induce host gene transcription did not correlate with the amount of
produced cAMP, as CT mediated only a limited rise of global
cAMP levels compared to that triggered by EdTx or forskolin. To
the contrary, this effect seems to be strongly influenced by the site of
cAMP production. In fact, while CyaA- and forskolin-elicited
increase of cAMP concentration is particularly strong below the
plasma membrane [16], EdTx [16] and CT [53] cause extensive
cAMP rise in the perinuclear region. Indeed, compartmentalization
is of prominent importance in cAMP-dependent signaling in many
cell types, including T lymphocytes, as it allows specific interactions
of PKA with its targets and therefore distinct signaling outputs [54–
56]. The presentdata indicate that perinuclear production of cAMP
is particularly efficient in inducing pCREB association with
transcriptionally active chromatin. Therefore, localization of the
enzymatic activity of EdTx to the perinuclear region appears to be a
specific feature of its intoxication mechanism with defined
functional consequences. A selected cytosolic localization of the
adenylate cyclase activity could explain the reports that Pseudomonas
aeruginosa ExoY has distinct effects on endothelial cell permeability
Figure 7. Inhibition of CREB re-phosphorylation in cells pre-treated with EdTx, CT, CyaA or forskolin. Jurkat cells were incubated with
EdTx (10 nM EF+40 nM PA), CT (3 nM), CyaA (5 nM), or forskolin (25 mM) and 16 or 24 h after this first treatment, CREB phosphorylation was re-
stimulated by addition of forskolin (25 mM) or by a-CD3 antibody mediated cross-linking of the TCR for 30 min. Cells were then lysed and processed
for western blotting with antibody against S133-pCREB. The intensity of each band was determined using the software Quantity One (Bio-Rad) and
was corrected for different loadings using the corresponding value of actin as control. The value of untreated samples was set equal to 1. The blots
show one representative experiment and the graphs give the mean and standard deviation of three independent experiments.
doi:10.1371/journal.pone.0003564.g007
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membrane [57–59].
CREB mediates expression of a high number of genes that are
implicated in a wide array of cell functions, including transcrip-
tion, cell cycle, and immune regulation [41,50]. We found that
EdTx-elicited CREB phosphorylation is specifically mediated by
PKA, whereas, during T cell activation, CREB phosphorylation
induced by cross-linking of TCR is mainly mediated by proteins of
the MAPK pathway, in particular RSK2 [46,47] and MSK1 [48].
RSK1/2 and MSK1 were not phosphorylated upon stimulation
with EdTx, in keeping with the finding that EdTx blocks
phosphorylation of their upstream kinases MEK and ERK
[22,24]. This suggests that EdTx and TCR cross-linking may
elicit distinct genetic programs. For instance, the genes coding for
IL-2, IL-2 receptor, interferon-c, tumor necrosis factor a, and the
early activation marker CD69 contain CRE sites [41,46,60], but
their expression was inhibited by EdTx [24]. On the contrary,
PKA was reported to downregulate the expression of cyclin D3
and up regulate p27
kip1, which block cell growth [61,62]. This
mechanism could also partially account for EdTx-induced
suppression of T cell proliferation [22,24].
We also report here that, although EdTx initially induces
CREB phosphorylation and gene expression, after a prolonged
incubation it clearly inhibits the subsequent phosphorylation of
CREB induced by forskolin or by TCR cross-linking. This
property likely depends on the massive and long-lasting cAMP
synthesis caused by EdTx, which probably fuels negative feedback
mechanisms of CREB phosphorylation [41]. Interestingly, elevat-
ed cAMP levels and hyperactivation of PKA have been implicated
in T cell anergy and dysfunction [63]. Possibly, the site of cAMP
production might also contribute to inhibition of CREB
phosphorylation. Indeed, CT, which similarly induces cAMP
elevation in the perinuclear region, was also able to suppress
CREB phosphorylation provoked by TCR cross-linking, whereas
CyaA and forskolin had a limited effect. These findings indicate
that intoxication with EdTx prior to bacterial stimulation of T cells
may suppress their activity by preventing an essential step in T cell
activation, that is CREB phosphorylation, and thereby allow the
pathogen to escape the immune response. Further, a two-phase
mechanism of action could contribute to explain the in vivo
observation that the effects on T lymphocyte cytokine secretion
change with the duration of EdTx intoxication [22]. This
subversion mechanism of host cell functions, by untimely
phosphorylation of CREB followed by inhibition of CREB
activity, is likely to operate in other cell types besides T cells, as
EdTx-mediated CREB phosphorylation was observed also in
macrophages [64–66]. Moreover, this mechanism of action may
be relevant to a number of bacterial toxins hitting upon host cell
signaling, as suggested by the fact that not only EdTx but also CT
is able to impair TCR-mediated CREB phosphorylation.
In conclusion, we identify PKA and CREB as targets of
inhibition of T cell function caused by EdTx. Our data suggest
that EdTx displays its action in two distinct phases: first, EdTx
induces PKA-dependent CREB phosphorylation and expression
of genes under the control of CRE; then, EdTx prevents CREB
phosphorylation in response to incoming stimuli. This is a novel
mode of intoxication by bacterial toxins acting on cellular
signaling. Comparison of EdTx activity with that of other
cAMP-elevating agents such as CT, CyaA and forskolin showed
that EdTx is particularly efficient in affecting T cell function,
probably owing to the duration and site of cAMP production.
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